Search - tctmd.com

Displaying 801 - 820 of 935

Sort: Relevancy | Date

News Daily News

CADUCEUS: Autologous Stem Cells Safely Reverse Some MI Damage

September 27, 2013

News Daily News

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Yael L. Maxwell

September 27, 2013

News Daily News

US Registry Study Explores Factors Tied to ‘Inappropriate’ PCI

Caitlin E. Cox

September 20, 2013

News Daily News

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

September 20, 2013

News Daily News

Meta-analysis: Cell Therapy Improves LV Function in Majority of STEMI Patients

Jason Kahn

September 20, 2013

News Daily News

Baroreflex Sensitivity May Help Target Likely Responders to Renal Denervation

September 13, 2013

News Conference News ESC 2013

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Caitlin E. Cox

September 04, 2013

News Conference News ESC 2013

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Caitlin E. Cox

September 04, 2013

News Industry News

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

September 03, 2013

News Industry News

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

September 02, 2013

News Daily News

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

July 19, 2013

News Daily News

Pulmonary Denervation Shows Promise for Resistant Pulmonary Hypertension

Yael L. Maxwell

July 19, 2013

News Daily News

Heart Rate-Lowering Drug Shows Promise for STEMI Patients After PCI

L.A. McKeown

July 19, 2013

News Daily News

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Caitlin E. Cox

July 11, 2013

News Daily News

EnligHTN I Published: Renal Denervation with Multielectrode Catheter Safe, Effective

Caitlin E. Cox

July 05, 2013

News Daily News

STEMI Marked by Microvascular Dysfunction Linked to Higher Long-term Mortality

Jason Kahn

June 28, 2013

News Daily News

Renal Denervation Lowers Ambulatory BP Measurements in Resistant Hypertension

June 28, 2013

News Industry News

First BioVentrix Revivent® System Clinical Patients Sustain 39.6% Improvement in Heart Function at One Year

June 27, 2013

News Industry News

St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure

June 04, 2013

News Industry News

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

May 23, 2013

Advertisement

CADUCEUS: Autologous Stem Cells Safely Reverse Some MI Damage

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

US Registry Study Explores Factors Tied to ‘Inappropriate’ PCI

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

Meta-analysis: Cell Therapy Improves LV Function in Majority of STEMI Patients

Baroreflex Sensitivity May Help Target Likely Responders to Renal Denervation

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

Pulmonary Denervation Shows Promise for Resistant Pulmonary Hypertension

Heart Rate-Lowering Drug Shows Promise for STEMI Patients After PCI

Studies Zero in on Baseline Factors That Influence TAVR Outcome

EnligHTN I Published: Renal Denervation with Multielectrode Catheter Safe, Effective

STEMI Marked by Microvascular Dysfunction Linked to Higher Long-term Mortality

Renal Denervation Lowers Ambulatory BP Measurements in Resistant Hypertension

First BioVentrix Revivent® System Clinical Patients Sustain 39.6% Improvement in Heart Function at One Year

St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content